[{"Assets_0_Q2_USD":56436000.0,"CommonStockSharesOutstanding_0_Q2_shares":18393000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":1730000.0,"NetIncomeLoss_1_Q2_USD":331000.0,"NetIncomeLoss_2_Q2_USD":-1577000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":18343000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":18286000.0,"StockholdersEquity_0_Q2_USD":51142000.0,"Ticker":"FLGT","CIK":"1674930","name":"FULGENT GENETICS, INC.","OfficialName":"Fulgent Genetics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1793543393.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20190812"}]